Events
ExpreS2ion Biotechnologies is represented at the forthcoming partnering/investor events and scientific conferences – please feel free to reach out for a meeting.
- UPCOMING -
Virtual
Thu, 15 Aug, 10:00 AM
ExpreS2ion CEO Bent Frandsen and CFO Keith Alexander will present the 2024 second quarter interim results and answer investors’ questions.
- PREVIOUS -
Edinburgh International Conference Centre (EICC)
Sun, 23 Jun, 02:30 PM
The next ExpreS2ion scientific presence will be at the ESACT meeting in Edinburgh where we will be presenting a poster…
Virtual
Fri, 14 Jun, 11:00 AM
ExpreS2ion is carrying out a rights issue with preferential rights for existing shareholders, through which the company is aiming to…
Virtual
Tue, 04 Jun, 12:00 PM
CEO Bent Frandsen will be participating in the H.C. Andersen Life Science Seminar on June 4th. The event is a good opportunity for…
Medicon Village in Lund, Sweden
Thu, 30 May, 11:00 AM
Bent Frandsen will present at The Global Forum 2024, an event focusing on international expansion, partnerships, and capital attraction. The…
Virtual
Thu, 16 May, 10:00 AM
ExpreS2ion CEO Bent Frandsen and CFO Keith Alexander will present the 2024 first quarter results and answer investors’ questions. More…
London, UK
Tue, 23 Apr, 12:00 AM
We look forward to attending Cambridge Healthtech Institute’s Inaugural event – Therapeutic Cancer Vaccines – showcasing Immunological Advances for Cancer…
Stockholm, Sweden
Wed, 17 Apr, 04:25 PM
Join us for a live update from our CEO, Bent Frandsen, at Aktiespararna’s Life Science Investor Day in Stockholm. The…
Washington D.C.
Mon, 01 Apr, 12:00 AM
Early April, we look forward to sending a team of ExpreS2ion executives to the World Vaccine Congress in Washington D.C.…
Copenhagen, Denmark
Wed, 20 Mar
Økonomisk Ugebrev is a Danish journal that is published every Monday . The weekly newsletter deals with trends within economics and business life and is primarily addressed to managers in the financial sector. The…
Barcelona, Spain
Tue, 19 Mar, 12:00 AM
ExpreS2ion Senior Vice President of R&D and Technology Dr. Max Søgaard is invited to present in the Cell Line Development track at…